Conclusions
schizophrenia
ADVERSE EFFECTS
In summary, our study showed that pharmacogenomics-guided treatment of antipsychotics significantly improved the clinical outcomes in terms of drug efficacy and adverse effects of prolactin elevation in patients with schizophrenia. Multigenetic pharmacogenomics testing can be an effective tool to guide the treatment of schizophrenia.